Top Heart Pump Device Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Heart Pump Device Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Heart Pump Device industry players.

Heart Pump Device Market Competitive Landscape

The heart pump device market is highly competitive, with several key players vying for market share. The competitive landscape is characterized by intense rivalry, continuous technological advancements, strategic collaborations, and product innovations. Some of the prominent players in the market. These companies have a strong global presence and offer a wide range of heart pump devices catering to different indications and patient needs. Additionally, strategic partnerships, acquisitions, and collaborations with other companies and healthcare institutions are common strategies employed by key players to expand their market presence and gain a competitive edge.

Heart Pump Device Market Top Player’s Company Profile

  • Abbott Laboratories (US)
  • Medtronic PLC (Ireland)
  • LivaNova PLC (United Kingdom)
  • Berlin Heart GmbH (Germany)
  • SynCardia Systems, LLC (US)
  • Abiomed, Inc. (US)
  • Getinge AB (Sweden)
  • Terumo Corporation (Japan)
  • Teleflex Incorporated (US)
  • Jarvik Heart, Inc. (US)
  • Fresenius Medical Care AG & Co. KGaA (Germany)
  • Calon Cardio (United Kingdom)
  • CardiacAssist, Inc. (US)
  • BiVACOR Inc. (Australia)
  • Leviticus Cardio Ltd. (Israel)
  • CARMAT SA (France)
  • FineHeart SA (France)
  • MyLVAD (US)
  • MicroPort Scientific Corporation (China)
  • TandemLife, a LivaNova company (US)

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Global Heart Pump Devices Market size was valued at USD 2.58 Billion in 2024 and is poised to grow from USD 3.03 Billion in 2025 to USD 10.93 Billion by 2033, growing at a CAGR of 17.4% during the forecast period (2026–2033).

The Heart Pump Device Market is characterized by fierce competition between regional and international players, which is fueled by innovation, and the growing need for sophisticated cardiac care. Businesses are spending money on AI-assisted pump technologies, remote monitoring, and miniaturization. Global reach and portfolio diversification are accelerated through strategic mergers and acquisitions. Collaborations with medical facilities and research centers also improve clinical adoption and device development. Through innovation and specialized care solutions, these Heart Pump Device Market strategies are strengthening leadership and influencing the direction of cardiac support in the future. 'ABIOMED ', 'BiVACOR Inc. ', 'Berlin Heart ', 'CARMAT ', 'CorWave SA ', 'Evaheart, Inc. ', 'Fresenius SE & Co. KGaA ', 'Getinge AB ', 'Jarvik Heart ', 'Leviticus Cardio ', 'LivaNova PLC ', 'Medtronic plc ', 'SynCardia Systems, LLC ', 'Teleflex Incorporated'

One of the main factors driving the heart pump devices industry analysis is the rising number of patients with advanced heart failure. Since there are still few heart transplants available, mechanical circulatory support is becoming crucial for survival. As hospitals embrace long-term devices like LVADs and TAHs as life-saving alternatives, the increase in critical cardiac cases is a major factor in the growth for Heart Pump Device Market size.

Shift Toward Minimally Invasive Implantation: One of the most significant heart pump devices industry trends is the growing preference for minimally invasive surgical techniques in VAD implantation. These techniques shorten recovery periods, complications, and hospital stays. Manufacturers are being pushed to create small, and easy-to-use devices that facilitate less invasive procedures as hospitals strive to maximize patient outcomes and procedural efficiency.

According to heart pump devices regional forecast, North America leads the market because of its sophisticated cardiac infrastructure, high level of awareness, and advantageous reimbursement policies. With widespread VAD adoption in both public and private healthcare systems, the region exhibits a high level of market penetration.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Heart Pump Device Market
Heart Pump Device Market

Report ID: SQMIG35A2376

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE